Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
- SYNAPSE study investigators
- Eastern Virginia Medical School
- Ghent University
- Stockholm University
- Amsterdam University Medical Center
- Centre Hospitalier de L'Universite de Montreal
- Heinrich Heine University Düsseldorf
- University of Pittsburgh
- GlaxoSmithKline
- Guy's and St Thomas' NHS Foundation Trust
- St Thomas' Hospital
Research output: Contribution to journal › Article › peer-review
644
Scopus
citations